DK1480646T3 - Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfælde - Google Patents

Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfælde

Info

Publication number
DK1480646T3
DK1480646T3 DK03714776T DK03714776T DK1480646T3 DK 1480646 T3 DK1480646 T3 DK 1480646T3 DK 03714776 T DK03714776 T DK 03714776T DK 03714776 T DK03714776 T DK 03714776T DK 1480646 T3 DK1480646 T3 DK 1480646T3
Authority
DK
Denmark
Prior art keywords
infectives
immunomodulators
preventive therapy
acute stroke
agents
Prior art date
Application number
DK03714776T
Other languages
English (en)
Inventor
Andreas Meisel
Konstantin Prass
Christian Meisel
Elke Halle
Ulrich Dirnagl
Hans Dieter Volk
Original Assignee
Charite Universitaetsmedizin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charite Universitaetsmedizin filed Critical Charite Universitaetsmedizin
Application granted granted Critical
Publication of DK1480646T3 publication Critical patent/DK1480646T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03714776T 2002-03-05 2003-03-05 Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfælde DK1480646T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10210536 2002-03-05
DE10218328A DE10218328A1 (de) 2002-03-05 2002-04-24 Mittel zur präventiven Therapie nach akutem Schlaganfall
PCT/EP2003/002246 WO2003074057A1 (de) 2002-03-05 2003-03-05 Antiinfektiva und/oder immunnodulatoren zur präventiven therapie nach akutem schlaganfall

Publications (1)

Publication Number Publication Date
DK1480646T3 true DK1480646T3 (da) 2008-11-24

Family

ID=27789739

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03714776T DK1480646T3 (da) 2002-03-05 2003-03-05 Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfælde

Country Status (15)

Country Link
US (1) US8673934B2 (da)
EP (1) EP1480646B1 (da)
JP (1) JP2005525361A (da)
CN (1) CN1652785A (da)
AT (1) ATE402702T1 (da)
AU (1) AU2003219016B2 (da)
BR (1) BRPI0308256A2 (da)
CA (1) CA2478133A1 (da)
DE (2) DE10218328A1 (da)
DK (1) DK1480646T3 (da)
ES (1) ES2311093T3 (da)
MX (1) MXPA04008573A (da)
PT (1) PT1480646E (da)
RU (1) RU2327454C2 (da)
WO (1) WO2003074057A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005053679A1 (de) * 2005-06-24 2006-12-28 Bayer Healthcare Ag Therapeutischer Einsatz von Moxifloxacin zur Rekonstruktion von Funktionsstörungen des Immunsystems
DE102007020152A1 (de) * 2007-04-26 2008-10-30 Charité - Universitätsmedizin Berlin Mittel zur antiinfektiven Behandlung eines Patienten
WO2009134489A2 (en) * 2008-02-01 2009-11-05 Albany Medical College Blockage of interferon-gamma for prevention of polymicrobial synergy
RU2571282C1 (ru) * 2014-05-22 2015-12-20 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства Способ лечения инсульта
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
EP3833665B1 (en) 2018-08-09 2023-07-19 Antabio SAS Diazabicyclooctanones as inhibitors of serine beta-lactamases
CN110964778B (zh) * 2018-09-29 2024-02-23 南方医科大学珠江医院 肠杆菌科作为缺血性脑卒中生物标志物的用途
EP4574146A1 (en) * 2023-12-18 2025-06-25 Telara Pharma S.L. Dhp-i inhibitors for use as neuroprotectants and in the treatment of neuroinflammatory diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4437868A1 (de) * 1994-10-22 1996-04-25 Boehringer Ingelheim Int Behandlung von HLA-DR-assoziierter Immundefizienz mit Interferon-gamma
CN1194828A (zh) * 1998-04-22 1998-10-07 王卫东 具有协同作用的美洛西林和舒巴坦的药物组合物
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
KR20020072563A (ko) * 1999-12-30 2002-09-16 인터뮨, 인크. γ―ＩＦＮ 액체―소적 에어로졸 및 방법

Also Published As

Publication number Publication date
WO2003074057A1 (de) 2003-09-12
RU2327454C2 (ru) 2008-06-27
MXPA04008573A (es) 2005-09-08
JP2005525361A (ja) 2005-08-25
ATE402702T1 (de) 2008-08-15
ES2311093T3 (es) 2009-02-01
CN1652785A (zh) 2005-08-10
EP1480646B1 (de) 2008-07-30
PT1480646E (pt) 2008-11-03
AU2003219016B2 (en) 2008-10-16
AU2003219016A1 (en) 2003-09-16
EP1480646A1 (de) 2004-12-01
DE10218328A1 (de) 2003-09-25
RU2004129591A (ru) 2005-09-20
US8673934B2 (en) 2014-03-18
DE50310242D1 (de) 2008-09-11
CA2478133A1 (en) 2003-09-12
BRPI0308256A2 (pt) 2016-06-21
US20050234089A1 (en) 2005-10-20
WO2003074057A8 (de) 2005-09-29

Similar Documents

Publication Publication Date Title
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
MX2019004450A (es) Derivados de piperidina como inhibidores de proteasa especifica de ubiquitina 7.
CL2007001996A1 (es) Compuestos derivados de heteroarilos nitrogenados sustituidos con fenilo, inhibidores de la produccion de citoquinas; composicion farmaceutica que los comprende; y sus usos en el tratamiento del cancer, infecciones, enfermedades inflamatorias y autoinmunes.
UA89220C2 (ru) Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы
NO20082376L (no) Farmasoytiske sammensetninger
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
NO20081878L (no) Diacylindazolderivater som lipase- og fosfolipaseinhibitorer
CL2008001782A1 (es) Uso de una composicion que comprende un compuesto derivado de heterociclo para tratar o prevenir la perdida de flujo intestinal; composicion que comprende dicho compusto; y kit que comprende la composicion.
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
IL291080A (en) Systems, methods, and compounds for early and rapid detection of infection by host RNA biomarkers and early detection of covid-19 infection in humans
DK1635783T3 (da) Farmaceutiske præparater omfattende fentanyl til intranasal levering
MY200841A (en) Influenza Virus Vaccines and Uses Thereof
MX2022014161A (es) Vacunas contra sars-cov-2.
DK1648484T3 (da) Fremgangsmåde til behandling af arthritis-tilstande
DK1480646T3 (da) Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfælde
DK4110292T3 (da) Flydende, farmaceutisk sammensætning omfattende ensifentrin og glycopyrrolat
BR112018010255A2 (pt) antibióticos macrocíclicos de amplo espectro
NO20035328D0 (no) Nye forbindelser og preparater som katepsinhibitorer
IL309182A (en) Protease inhibitors for the treatment of corona virus infections
GEAP202115006A (en) Combination of bcl-2 inhibitor and mcl-1 inhibitor, uses and pharmaceutical compositions thereof
BRPI0411168A (pt) composição para o tratamento dos cabelos, usos de uma composição e método de tratamento dos cabelos
IT202300012030A1 (it) Banco da lavoro, particolarmente per la preparazione di piastre di carpenteria di grandi dimensioni e spessori, e procedimento di ancoraggio di una o più piastre di carpenteria, particolarmente di grandi dimensioni e spessori.
NO20062229L (no) Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er)
IT201900024760A1 (it) Sistema di gestione di servizi di assistenza di macchine e/o impianti per la lavorazione di pezzi in legno e metodo di funzionamento relativo
IT202000001351A1 (it) Impianto per la movimentazione di una valvola di sicurezza antieruzione e procedimento per movimentare detta valvola